The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
Smad7 was initially identified as an inhibitor of Transforming growth factor (TGF)-β due mainly to its ability to bind TGF-β receptor type I and prevent TGF-β-associated Smad signaling. More recently, it has been demonstrated that Smad7 can interact with other intracellular proteins and regulate al...
Main Authors: | Carmine Stolfi, Irene Marafini, Veronica De Simone, Francesco Pallone, Giovanni Monteleone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/12/23774 |
Similar Items
-
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
by: Carmine Stolfi, et al.
Published: (2020-12-01) -
Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword
by: Edoardo Troncone, et al.
Published: (2019-05-01) -
Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers
by: Morteza Abyadeh, et al.
Published: (2020-11-01) -
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
by: Edoardo Troncone, et al.
Published: (2021-04-01) -
The platinum coordination complex inhibits cell invasion-migration and epithelial-to-mesenchymal transition by altering the TGF-β-SMAD pathway in colorectal cancer
by: Maha-Hamadien Abdulla, et al.
Published: (2023-11-01)